#$%^&*AU2020203081A120200528.pdf#####ABSTRACT FORMULATION The present invention relates to a liquid pharmaceutical composition suitable for administration by inhalation which comprises a diluent and a suspension of particles of 9,10dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one (RPL554) or a pharmaceutically acceptable salt thereof. Also described is a liquid pharmaceutical composition according to the invention for use in the treatment of the human or animal body.1/3 Transform of RL PCS 2 h and 5 h 4Fu 1 2 ~RN Tiur It
展开▼
机译：＃$％^＆* AU2020203081A120200528.pdf #####抽象公式本发明涉及适合于吸入给药，包括稀释剂和9,10颗粒的悬浮液二甲氧基-2-（2,4,6-三甲基苯基亚氨基）-3-（N-氨基甲酰基-2-氨基乙基）-3,4,6,7四氢-2H-嘧啶[6,1-a]异喹啉-4-酮（RPL554）或药学上可接受的其盐。还描述了根据本发明的液体药物组合物。本发明用于治疗人体或动物体。1/3RL PCS的转换2小时和5小时4赋12〜RNTiur It
展开▼
